Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
暂无分享,去创建一个
Elizabeth Miller | N. Andrews | M. Ramsay | E. Miller | E. Kaczmarski | Caroline L Trotter | Nick J Andrews | Edward B Kaczmarski | Mary E Ramsay | C. Trotter
[1] N. Andrews,et al. Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom. , 2002, The Journal of infectious diseases.
[2] N. Andrews,et al. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England , 2001, The Lancet.
[3] N. Andrews,et al. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis , 2003, BMJ : British Medical Journal.
[4] M. Ramsay,et al. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. , 2001, Vaccine.
[5] J. McVernon,et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. , 2003, The Journal of infectious diseases.